ViTAA Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
ViTAA General Information
Description
Developer of medical assessment devices designed for personalized medicine for the improved management of patients. The company's platform facilitates cloud-based software, with integrated artificial intelligence, that will significantly improve how patients with aortic aneurysms will be managed and treated, enabling physicians and doctors to treat the right patient at the right time with the right technique.
Contact Information
Website
www.vitaamedical.comCorporate Office
- 2590 Rue de Rouen
- Montreal, Quebec H2K 1M6
- Canada
Corporate Office
- 2590 Rue de Rouen
- Montreal, Quebec H2K 1M6
- Canada
ViTAA Timeline
ViTAA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 7. Seed Round | 26-Jun-2023 | Completed | Generating Revenue | |||
| 6. Seed Round | 29-Aug-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Sep-2021 | Completed | Startup | |||
| 4. Seed Round | 03-Jun-2021 | Completed | Startup | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Spin-Off | 01-Jan-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ViTAA Patents
ViTAA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026022703-A1 | Method and system for classifying aneurysm in a blood vessel | Pending | 22-Jul-2024 | ||
| AU-2024221073-A1 | Method and system for determining a deformation of a blood vessel | Pending | 17-Feb-2023 | ||
| EP-4666246-A1 | Method and system for determining a deformation of a blood vessel | Pending | 17-Feb-2023 | ||
| US-20260237065-A1 | Method and system for determining a deformation of a blood vessel | Pending | 17-Feb-2023 | ||
| WO-2024171153-A1 | Method and system for determining a deformation of a blood vessel | Inactive | 17-Feb-2023 | G06T7/0016 |
ViTAA Signals
ViTAA Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3CC | Third Culture Capital | Venture Capital | Minority | ||
| Investissement Quebec | PE/Buyout | Majority | ||
| INOVAIT | Government | Minority | ||
| Somel Investments | Venture Capital | Minority | ||
| UCeed | Venture Capital | Minority |
ViTAA FAQs
-
When was ViTAA founded?
ViTAA was founded in 2019.
-
Where is ViTAA headquartered?
ViTAA is headquartered in Montreal, Canada.
-
What is the size of ViTAA?
ViTAA has 31 total employees.
-
What industry is ViTAA in?
ViTAA’s primary industry is Diagnostic Equipment.
-
Is ViTAA a private or public company?
ViTAA is a Private company.
-
What is ViTAA’s current revenue?
The current revenue for ViTAA is .
-
How much funding has ViTAA raised over time?
ViTAA has raised $6.12M.
-
Who are ViTAA’s investors?
3CC | Third Culture Capital, Investissement Quebec, INOVAIT, Somel Investments, and UCeed are 5 of 9 investors who have invested in ViTAA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process